LGALS9 and breast neoplasm: Importantly, as indicated above, our results indicate that galectin-9 is unlikely to be secreted by breast tumors, since its levels do not increase in patient blood plasma and the studied human breast cancer cell lines were incapable of secreting galectin-9.